GlobeNewswire
Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
📈
AI Sentiment
Highly Positive
9/10
Latest updates and market news for ABVX
AI Sentiment
Highly Positive
9/10
AI Sentiment
Positive
7/10
Share this news page